Does Rallies track congressional trades in SLP?

Yes. Rallies tracks politician and congressional stock disclosures for SLP, including reported purchases, sales, dates, owners, and trade amounts when available.

Is SLP research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SLP. It does not provide personalized investment advice.

SLP (Simulations Plus, Inc.) Stock Analysis - Politician Trades

Simulations Plus, Inc. (SLP) is a publicly traded Healthcare sector company. As of May 21, 2026, SLP trades at $14.39 with a market cap of $278.43M and a P/E ratio of -4.57. SLP moved +2.77% today. Year to date, SLP is -24.64%; over the trailing twelve months it is -54.90%. Its 52-week range spans $11.09 to $37.67. Analyst consensus is buy with an average price target of $16.00. Rallies surfaces SLP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded SLP stock?

Rallies tracks politician and congressional stock disclosures for SLP, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

SLP Key Metrics

Key financial metrics for SLP
Metric	Value
Price	$14.39
Market Cap	$278.43M
P/E Ratio	-4.57
EPS	$-3.13
Dividend Yield	0.06%
52-Week High	$37.67
52-Week Low	$11.09
Volume	0
Avg Volume	0
Revenue (TTM)	$80.53M
Net Income	$-62.79M
Gross Margin	61.97%

Latest SLP News

Simulations Plus Q2 Revenue Rises 8% to $24.3M, Guides $79M–$82M Fiscal Sales — Apr 10, 2026
Simulations Plus to Deploy AI-Enabled GastroPlus, MonolixSuite in Pharma Collaborations — Mar 26, 2026
Certara To Conclude Regulatory Services Review, Reports 1.5 Book-to-Bill and 17% Q4 Services Surge — Mar 8, 2026
Simulations Plus Approves 950,000-Share Equity Plan Increase, Ratifies Auditor — Feb 15, 2026
Simulations Plus Extends FDA and NIEHS Collaborations to Advance Drug Safety Modeling — Feb 10, 2026

Recent SLP Insider Trades

Fiedler-Kelly Jill sold 1.00K (~$16.53K) on May 11, 2026.
DiBella John Anthony II sold 1.00K (~$14.98K) on May 4, 2026.
WOLTOSZ WALTER S sold 15.00K (~$226.95K) on May 4, 2026.

SLP Analyst Consensus

3 analysts cover SLP: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $16.00.

Common questions about SLP

Which politicians traded SLP stock?: Rallies tracks politician and congressional stock disclosures for SLP, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in SLP?: Yes. Rallies tracks politician and congressional stock disclosures for SLP, including reported purchases, sales, dates, owners, and trade amounts when available.
Is SLP research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SLP. It does not provide personalized investment advice.